Exemplaires (1)

Exemplaires (1)

Dépouillements

The Role of Audiology in the Care of Persons with Diabetes / Kathy Dowd in Seminars in hearing, Vol. 40, n°4 (November 2019)  

Public ISBD [article]  inSeminars in hearing > Vol. 40, n°4 (November 2019) . - p. 279-280 Titre : The Role of Audiology in the Care of Persons with Diabetes Type de document : Article Auteurs : Kathy Dowd, Auteur Année de publication : 2019 Article en page(s) : p. 279-280 Langues : Anglais (eng) Résumé : Hearing loss and balance issues contributing to falls are common problems for persons with diabetes (PWD). According to the Centers for Disease Control and Prevention (CDC), hearing loss and risk of falls are under recognized in diabetes care. Audiology should play an important role in the care of PWD, but currently many PWD are not medically monitored and managed for hearing loss and risk of falls. Proper care will require a change in audiological practice and in educational programs preparing students for careers in audiology. To this end, The Audiology Project (TAP) has focused its efforts on creating awareness of the need for audiological care in the management of PWD. TAP is an integrated audiology initiative that seeks to promote early diagnosis, treatment, and management of hearing and balance disorders associated with diabetes, thereby improving quality of life for PWD. Additionally, TAP seeks to provide educational programs to universities, government entities, and continuing education for practitioners regarding diabetes as a chronic disease and the needed audiological management of resulting hearing and balance issues. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250041 [article] The Role of Audiology in the Care of Persons with Diabetes [Article] / Kathy Dowd, Auteur . - 2019 . - p. 279-280. Langues : Anglais (eng) in Seminars in hearing > Vol. 40, n°4 (November 2019) . - p. 279-280 Résumé : Hearing loss and balance issues contributing to falls are common problems for persons with diabetes (PWD). According to the Centers for Disease Control and Prevention (CDC), hearing loss and risk of falls are under recognized in diabetes care. Audiology should play an important role in the care of PWD, but currently many PWD are not medically monitored and managed for hearing loss and risk of falls. Proper care will require a change in audiological practice and in educational programs preparing students for careers in audiology. To this end, The Audiology Project (TAP) has focused its efforts on creating awareness of the need for audiological care in the management of PWD. TAP is an integrated audiology initiative that seeks to promote early diagnosis, treatment, and management of hearing and balance disorders associated with diabetes, thereby improving quality of life for PWD. Additionally, TAP seeks to provide educational programs to universities, government entities, and continuing education for practitioners regarding diabetes as a chronic disease and the needed audiological management of resulting hearing and balance issues. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250041

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Seminars in hearing. Vol. 40, n°4 (November 2019)	Périodique papier	Ixelles	Rez	Exclu du prêt

Epidemiology of Diabetes and Hearing Loss / Rachael R. Baiduc in Seminars in hearing, Vol. 40, n°4 (November 2019)  

Public ISBD [article]  inSeminars in hearing > Vol. 40, n°4 (November 2019) . - p. 281-291 Titre : Epidemiology of Diabetes and Hearing Loss Type de document : Article Auteurs : Rachael R. Baiduc ; Elizabeth P. Helzner Année de publication : 2019 Article en page(s) : p. 281-291 Langues : Anglais (eng) Descripteurs : HE Vinci Diabète ; Épidémiologie ; Perte d'audition ; Surdité Résumé : Hearing loss is a highly prevalent chronic condition. In addition to age, sex, noise exposure, and genetic predisposition, cardiovascular disease and its antecedents may precipitate hearing loss. Of emerging interest is the connection between diabetes and auditory dysfunction. Cross-sectional studies consistently suggest that prevalence of hearing loss is higher in persons with diabetes compared with those without diabetes, especially among younger persons. Furthermore, longitudinal studies have demonstrated higher incidence of hearing loss in persons with diabetes compared to those without diabetes. These findings seem to hold for both type 1 and type 2 diabetes, although considerably more population-based evidence is available for type 2 diabetes. Data on gestational diabetes and hearing outcomes are limited, as are data relating diabetes to otologic sequelae such as fungal infection. Here, we examine evidence from epidemiologic studies of diabetes and hearing loss and consider clinical and laboratory data where population-based data are lacking. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250050 [article] Epidemiology of Diabetes and Hearing Loss [Article] / Rachael R. Baiduc ; Elizabeth P. Helzner . - 2019 . - p. 281-291. Langues : Anglais (eng) in Seminars in hearing > Vol. 40, n°4 (November 2019) . - p. 281-291 Descripteurs : HE Vinci Diabète ; Épidémiologie ; Perte d'audition ; Surdité Résumé : Hearing loss is a highly prevalent chronic condition. In addition to age, sex, noise exposure, and genetic predisposition, cardiovascular disease and its antecedents may precipitate hearing loss. Of emerging interest is the connection between diabetes and auditory dysfunction. Cross-sectional studies consistently suggest that prevalence of hearing loss is higher in persons with diabetes compared with those without diabetes, especially among younger persons. Furthermore, longitudinal studies have demonstrated higher incidence of hearing loss in persons with diabetes compared to those without diabetes. These findings seem to hold for both type 1 and type 2 diabetes, although considerably more population-based evidence is available for type 2 diabetes. Data on gestational diabetes and hearing outcomes are limited, as are data relating diabetes to otologic sequelae such as fungal infection. Here, we examine evidence from epidemiologic studies of diabetes and hearing loss and consider clinical and laboratory data where population-based data are lacking. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250050

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Seminars in hearing. Vol. 40, n°4 (November 2019)	Périodique papier	Ixelles	Rez	Exclu du prêt

Diabetes and Auditory-Vestibular Pathology / Saravanan Elangovan in Seminars in hearing, Vol. 40, n°4 (November 2019)  

Public ISBD [article]  inSeminars in hearing > Vol. 40, n°4 (November 2019) . - p. 292-299 Titre : Diabetes and Auditory-Vestibular Pathology Type de document : Article Auteurs : Saravanan Elangovan ; Christopher Spankovich, Auteur Année de publication : 2019 Article en page(s) : p. 292-299 Langues : Anglais (eng) Descripteurs : HE Vinci Animal ; Humain ; PATHOLOGIE VESTIBULAIRE ; Perte d'audition ; Surdité Résumé : The relationship between diabetes mellitus (DM) and the auditory/vestibular system has been investigated for more than a century. Most population-based investigations of hearing loss in persons with diabetes (PWD) have revealed a slow progressive, bilateral, high-frequency sensorineural hearing loss. Despite the growing research literature on the pathophysiology of DM-related hearing loss using various animal models and other human studies, knowledge of specific mechanism of the degenerative changes of the inner ear and/or auditory nerve is far from full elucidation. Recent investigations of the mechanisms underlying the association between hearing loss and DM suggest complex combined contributions of hyperglycemia, oxidative stress resulting in cochlear microangiopathy, and auditory neuropathy. An even lesser understood complication of DM is the effect on the vestibular system. Here we provide an overview of animal and human evidence of pathophysiological changes created by DM and its effects on auditory-vestibular anatomy and function. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250051 [article] Diabetes and Auditory-Vestibular Pathology [Article] / Saravanan Elangovan ; Christopher Spankovich, Auteur . - 2019 . - p. 292-299. Langues : Anglais (eng) in Seminars in hearing > Vol. 40, n°4 (November 2019) . - p. 292-299 Descripteurs : HE Vinci Animal ; Humain ; PATHOLOGIE VESTIBULAIRE ; Perte d'audition ; Surdité Résumé : The relationship between diabetes mellitus (DM) and the auditory/vestibular system has been investigated for more than a century. Most population-based investigations of hearing loss in persons with diabetes (PWD) have revealed a slow progressive, bilateral, high-frequency sensorineural hearing loss. Despite the growing research literature on the pathophysiology of DM-related hearing loss using various animal models and other human studies, knowledge of specific mechanism of the degenerative changes of the inner ear and/or auditory nerve is far from full elucidation. Recent investigations of the mechanisms underlying the association between hearing loss and DM suggest complex combined contributions of hyperglycemia, oxidative stress resulting in cochlear microangiopathy, and auditory neuropathy. An even lesser understood complication of DM is the effect on the vestibular system. Here we provide an overview of animal and human evidence of pathophysiological changes created by DM and its effects on auditory-vestibular anatomy and function. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250051

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Seminars in hearing. Vol. 40, n°4 (November 2019)	Périodique papier	Ixelles	Rez	Exclu du prêt

Diabetes and the Vestibular System / Erin G. Piker in Seminars in hearing, Vol. 40, n°4 (November 2019)  

Public ISBD [article]  inSeminars in hearing > Vol. 40, n°4 (November 2019) . - p. 300-307 Titre : Diabetes and the Vestibular System Type de document : Article Auteurs : Erin G. Piker ; Daniel J. Romero Année de publication : 2019 Article en page(s) : p. 300-307 Langues : Anglais (eng) Descripteurs : HE Vinci Diabète ; Système vestibulaire ; Vertige positionnel paroxystique benin (VPPB) (BPPV) Résumé : Falls are among the most injurious, costly, and feared conditions affecting older adults. Patients with diabetes have a significantly greater risk for falling due to complications affecting the sensory systems required for balance: vision, proprioception, and vestibular. The effects of diabetes mellitus on the vestibular system are perhaps the least understood of these systems. The vestibular system is complex, includes multiple structures, and is difficult and expensive to thoroughly assess. There is pathophysiologic evidence suggesting a direct effect of diabetes mellitus complications on the vestibular system, but there is limited clinical evidence regarding which specific vestibular structures are most adversely affected. Nevertheless, large population-based studies show that patients with diabetes are more likely to have vestibular loss, have a high prevalence of a specific vestibular disorder called benign paroxysmal positional vertigo, and are at a greater risk for falling. Based on the available evidence, a balance screening and an evaluation of benign paroxysmal positional vertigo, a common but easy to treat pathology, in patients with diabetes is recommended as well as counseling on falls risk and home modifications. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250052 [article] Diabetes and the Vestibular System [Article] / Erin G. Piker ; Daniel J. Romero . - 2019 . - p. 300-307. Langues : Anglais (eng) in Seminars in hearing > Vol. 40, n°4 (November 2019) . - p. 300-307 Descripteurs : HE Vinci Diabète ; Système vestibulaire ; Vertige positionnel paroxystique benin (VPPB) (BPPV) Résumé : Falls are among the most injurious, costly, and feared conditions affecting older adults. Patients with diabetes have a significantly greater risk for falling due to complications affecting the sensory systems required for balance: vision, proprioception, and vestibular. The effects of diabetes mellitus on the vestibular system are perhaps the least understood of these systems. The vestibular system is complex, includes multiple structures, and is difficult and expensive to thoroughly assess. There is pathophysiologic evidence suggesting a direct effect of diabetes mellitus complications on the vestibular system, but there is limited clinical evidence regarding which specific vestibular structures are most adversely affected. Nevertheless, large population-based studies show that patients with diabetes are more likely to have vestibular loss, have a high prevalence of a specific vestibular disorder called benign paroxysmal positional vertigo, and are at a greater risk for falling. Based on the available evidence, a balance screening and an evaluation of benign paroxysmal positional vertigo, a common but easy to treat pathology, in patients with diabetes is recommended as well as counseling on falls risk and home modifications. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250052

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Seminars in hearing. Vol. 40, n°4 (November 2019)	Périodique papier	Ixelles	Rez	Exclu du prêt

Evaluation and Management of Patients with Diabetes and Hearing Loss / Christopher Spankovich in Seminars in hearing, Vol. 40, n°4 (November 2019)  

Public ISBD [article]  inSeminars in hearing > Vol. 40, n°4 (November 2019) . - p. 308-314 Titre : Evaluation and Management of Patients with Diabetes and Hearing Loss Type de document : Article Auteurs : Christopher Spankovich ; Krishna Yerraguntla Année de publication : 2019 Article en page(s) : p. 308-314 Langues : Anglais (eng) Descripteurs : HE Vinci Acouphène ; Diabète ; Evaluation ; Management ; Perte d'audition ; Prévention ; Surdité Autres descripteurs Depistage Résumé : Diabetes mellitus is a significant risk factor for acquired hearing loss and tinnitus. Persons with diabetes (PWD) may present with hearing loss symptoms earlier in life than those without diabetes. Furthermore, diabetes may exacerbate risk for hearing loss related to noise exposure and ototoxic drugs. The purpose of this article is to provide recommendations for the prevention, screening, evaluation, and management of hearing loss in PWD. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250053 [article] Evaluation and Management of Patients with Diabetes and Hearing Loss [Article] / Christopher Spankovich ; Krishna Yerraguntla . - 2019 . - p. 308-314. Langues : Anglais (eng) in Seminars in hearing > Vol. 40, n°4 (November 2019) . - p. 308-314 Descripteurs : HE Vinci Acouphène ; Diabète ; Evaluation ; Management ; Perte d'audition ; Prévention ; Surdité Autres descripteurs Depistage Résumé : Diabetes mellitus is a significant risk factor for acquired hearing loss and tinnitus. Persons with diabetes (PWD) may present with hearing loss symptoms earlier in life than those without diabetes. Furthermore, diabetes may exacerbate risk for hearing loss related to noise exposure and ototoxic drugs. The purpose of this article is to provide recommendations for the prevention, screening, evaluation, and management of hearing loss in PWD. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250053

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Seminars in hearing. Vol. 40, n°4 (November 2019)	Périodique papier	Ixelles	Rez	Exclu du prêt

Auditory and Vestibular Side Effects of FDA-Approved Drugs for Diabetes / Robert M. DiSogra in Seminars in hearing, Vol. 40, n°4 (November 2019)  

Public ISBD [article]  inSeminars in hearing > Vol. 40, n°4 (November 2019) . - p. 315-325 Titre : Auditory and Vestibular Side Effects of FDA-Approved Drugs for Diabetes Type de document : Article Auteurs : Robert M. DiSogra ; Jerry Meece Année de publication : 2019 Article en page(s) : p. 315-325 Langues : Anglais (eng) Descripteurs : HE Vinci Diabète de type 1 ; Diabète de type 2 ; Effets indésirables Autres descripteurs Effets secondaires Résumé : As of September 10, 2019, there were 75 medications (oral/injectable/inhalants) approved by the U.S. Food and Drug Administration for diabetes management: 1 inhalant, 21 oral combinations, 22 injectable, and 31 oral medications (not in combination with any other diabetes drug). This article isolates the auditory and vestibular side effects of those drugs as reported by the drug's manufacturer as well as those side effects that could interfere with a balance assessment. Twenty of the 75 approved medications (26%) could have an auditory-related side effect. Hearing loss and tinnitus are not on the list. Only two, or just 3%, have vertigo and spinning as reported side effects (one each). More than 50% of the drugs will have some effect on a balance assessment. Audiologists who evaluate a patient with diabetes (PWD) are presented with symptoms that could be related to their diabetes medication. Although the manufacturer might report a side effect as rare or as a percentage from their clinical trials subjects, not all PWD will experience these adverse events. Auditory and vestibular side effects do not dominate the diabetes drug side effect list, but, rather, the most reported side effects could impact a balance assessment. The lists that appear in [Appendices A] and [B] should serve as a guide for all professionals involved in managing the PWD (i.e., audiologists, otolaryngologists, diabetes educators, pharmacists, optometrists, dentists, etc.). The list also serves as a counseling tool if a communication problem emerges during the progression of the diabetes. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250054 [article] Auditory and Vestibular Side Effects of FDA-Approved Drugs for Diabetes [Article] / Robert M. DiSogra ; Jerry Meece . - 2019 . - p. 315-325. Langues : Anglais (eng) in Seminars in hearing > Vol. 40, n°4 (November 2019) . - p. 315-325 Descripteurs : HE Vinci Diabète de type 1 ; Diabète de type 2 ; Effets indésirables Autres descripteurs Effets secondaires Résumé : As of September 10, 2019, there were 75 medications (oral/injectable/inhalants) approved by the U.S. Food and Drug Administration for diabetes management: 1 inhalant, 21 oral combinations, 22 injectable, and 31 oral medications (not in combination with any other diabetes drug). This article isolates the auditory and vestibular side effects of those drugs as reported by the drug's manufacturer as well as those side effects that could interfere with a balance assessment. Twenty of the 75 approved medications (26%) could have an auditory-related side effect. Hearing loss and tinnitus are not on the list. Only two, or just 3%, have vertigo and spinning as reported side effects (one each). More than 50% of the drugs will have some effect on a balance assessment. Audiologists who evaluate a patient with diabetes (PWD) are presented with symptoms that could be related to their diabetes medication. Although the manufacturer might report a side effect as rare or as a percentage from their clinical trials subjects, not all PWD will experience these adverse events. Auditory and vestibular side effects do not dominate the diabetes drug side effect list, but, rather, the most reported side effects could impact a balance assessment. The lists that appear in [Appendices A] and [B] should serve as a guide for all professionals involved in managing the PWD (i.e., audiologists, otolaryngologists, diabetes educators, pharmacists, optometrists, dentists, etc.). The list also serves as a counseling tool if a communication problem emerges during the progression of the diabetes. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.thieme-connect.com/products [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=250054

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Seminars in hearing. Vol. 40, n°4 (November 2019)	Périodique papier	Ixelles	Rez	Exclu du prêt

Exemplaires (1)

Exemplaires (1)

Exemplaires (1)

Exemplaires (1)

Exemplaires (1)

Exemplaires (1)

Exemplaires (1)

Exemplaires (1)

Exemplaires (1)

Exemplaires (1)